NM_002180.3:c.-2C>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002180.3(IGHMBP2):​c.-2C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 1,569,878 control chromosomes in the GnomAD database, including 41,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 3026 hom., cov: 35)
Exomes 𝑓: 0.23 ( 38756 hom. )

Consequence

IGHMBP2
NM_002180.3 5_prime_UTR

Scores

1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.0100
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
MRPL21 (HGNC:14479): (mitochondrial ribosomal protein L21) Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Multiple transcript variants encoding different isoforms were identified through sequence analysis although some may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 11-68903951-C-T is Benign according to our data. Variant chr11-68903951-C-T is described in ClinVar as [Benign]. Clinvar id is 258555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-68903951-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.246 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGHMBP2NM_002180.3 linkc.-2C>T 5_prime_UTR_variant Exon 1 of 15 ENST00000255078.8 NP_002171.2 P38935
MRPL21NM_181514.2 linkc.-141G>A upstream_gene_variant ENST00000362034.7 NP_852615.1 Q7Z2W9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGHMBP2ENST00000255078 linkc.-2C>T 5_prime_UTR_variant Exon 1 of 15 1 NM_002180.3 ENSP00000255078.4 P38935
MRPL21ENST00000362034.7 linkc.-141G>A upstream_gene_variant 1 NM_181514.2 ENSP00000354580.2 Q7Z2W9-1

Frequencies

GnomAD3 genomes
AF:
0.184
AC:
27968
AN:
152008
Hom.:
3023
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.305
Gnomad AMR
AF:
0.208
Gnomad ASJ
AF:
0.287
Gnomad EAS
AF:
0.0241
Gnomad SAS
AF:
0.0607
Gnomad FIN
AF:
0.124
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.250
Gnomad OTH
AF:
0.244
GnomAD3 exomes
AF:
0.187
AC:
33258
AN:
177460
Hom.:
3698
AF XY:
0.186
AC XY:
17875
AN XY:
96106
show subpopulations
Gnomad AFR exome
AF:
0.106
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.284
Gnomad EAS exome
AF:
0.0257
Gnomad SAS exome
AF:
0.0713
Gnomad FIN exome
AF:
0.132
Gnomad NFE exome
AF:
0.265
Gnomad OTH exome
AF:
0.225
GnomAD4 exome
AF:
0.225
AC:
319618
AN:
1417752
Hom.:
38756
Cov.:
40
AF XY:
0.221
AC XY:
155113
AN XY:
701912
show subpopulations
Gnomad4 AFR exome
AF:
0.100
Gnomad4 AMR exome
AF:
0.188
Gnomad4 ASJ exome
AF:
0.283
Gnomad4 EAS exome
AF:
0.0273
Gnomad4 SAS exome
AF:
0.0706
Gnomad4 FIN exome
AF:
0.133
Gnomad4 NFE exome
AF:
0.252
Gnomad4 OTH exome
AF:
0.214
GnomAD4 genome
AF:
0.184
AC:
27984
AN:
152126
Hom.:
3026
Cov.:
35
AF XY:
0.176
AC XY:
13124
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.103
Gnomad4 AMR
AF:
0.207
Gnomad4 ASJ
AF:
0.287
Gnomad4 EAS
AF:
0.0244
Gnomad4 SAS
AF:
0.0601
Gnomad4 FIN
AF:
0.124
Gnomad4 NFE
AF:
0.250
Gnomad4 OTH
AF:
0.241
Alfa
AF:
0.240
Hom.:
2515
Bravo
AF:
0.190
Asia WGS
AF:
0.0550
AC:
192
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 25% of total chromosomes in ExAC -

Apr 29, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 16, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive distal spinal muscular atrophy 1 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease axonal type 2S Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
15
DANN
Uncertain
0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4930624; hg19: chr11-68671419; API